Login / Signup

Perinatal Outcomes Associated With Metformin Use During Pregnancy in Women With Pregestational Type 2 Diabetes Mellitus.

Jennifer J YlandKrista F HuybrechtsAmelia K WesselinkLoreen StraubYu-Han ChiuEllen W SeelyElisabetta PatornoBrian T BatemanHelen MogunLauren A WiseSonia Hernández-Díaz
Published in: Diabetes care (2024)
Our findings were consistent with those reported in the MiTy randomized trial. Continuing metformin during pregnancy was not associated with increased risk of a neonatal composite adverse outcome. However, a possible metformin-associated risk of SGA warrants further consideration.
Keyphrases
  • pregnant women
  • glycemic control
  • type diabetes
  • emergency department
  • metabolic syndrome
  • cardiovascular disease
  • adipose tissue
  • adverse drug
  • medical education